The presence of high levels of leptin in obesity certainly makes it a prime candidate for amplifying the risk of NASH progression as both a first and second hit, which not only satisfies the two-hit hypothesis, but also is in line with the multi-hit paradigm [4]. Here, LEP is linked to metabolic dysfunction-associated steatohepatitis.